You are here

A Culture-Free Platform for Rapid Pathogen Identification

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI109913-01
Agency Tracking Number: R43AI109913
Amount: $299,310.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NIAID
Solicitation Number: PA10-123
Timeline
Solicitation Year: 2014
Award Year: 2014
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
125 CHISWICK RD, APT 212
BRIGHTON, MA 02135-5310
United States
DUNS: 78680117
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 ALON SINGER
 (617) 903-7931
 asinger@helixbind.com
Business Contact
 ALON SINGER
Phone: (617) 903-7931
Email: asinger@helixbind.com
Research Institution
 Stub
Abstract

DESCRIPTION (provided by applicant): A Culture-Free Platform for Rapid Pathogen Identification Project Summary Sepsis is a one of the leading causes of morbidity and mortality in the US, with more than 751,000 confirmed cases occurring every year and 210,000 mortalities. This high mortality rate (~30%) means that nearly 600 patients a day succumb to sepsis-related infections. In addition to the human toll, the economic burden is likewise immense, reaching 24B/year in the US, with an average cost of over 23,000 per patient. The key to treating sepsis properly is rapid and accurate identification of the causative microorganism (bacterial or fungal). Unfortunately, given the wide range of potential pathogens which can induce sepsis, the 'gold-standard' todayfor diagnosis remains culturing; which typically requires up to 3-5 days for accurate identification leading to a significant delay in the initiation of a targeted treatment protocol. The objective of this Small Business Innovation Research Phase I p

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government